GENinCode (LON:GENI) Stock Price Down 12.3% – Should You Sell?

Shares of GENinCode Plc (LON:GENIGet Free Report) fell 12.3% during trading on Tuesday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.50 ($0.03). 2,380,361 shares traded hands during trading, an increase of 222% from the average session volume of 740,144 shares. The stock had previously closed at GBX 2.85 ($0.04).

GENinCode Stock Performance

The stock’s 50-day moving average price is GBX 3.57 and its 200 day moving average price is GBX 4.09. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28. The company has a market cap of £4.44 million, a P/E ratio of -0.73 and a beta of 0.66.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.